Redeye adjusts our growth assumptions for the second half of 2023e based on strong organic growth ou...
Redeye’s view on the Q2 report. The organic growth trend continues to be weak, although the situatio...
Redeye retains its positive view of ADDvise following a strong Q2 report in line with the preliminar...
SRV reported Q2 figures that were lower than we estimated for both net sales (EUR 141.
• EBITA SEK 198m (-11% vs. ABGSCe, -8% vs. cons) • We expect cons.
Redeye states that Advenica’s Q2 report was stronger than our estimates on topline.
Överraskande bra rapport Som vi redan konstaterat på rapportdagen, så lyckades Orexo leverera en bra...
6% organisk tillväxt… Marknadsläget är fortsatt stabilt för de flesta av koncernens verksamheter och...
• Weakness in Architecture behind negative growth • Long-term negative EBIT revisions of 9% • Needs ...
VEF's share price is down 12% in SEK YTD despite: 1) a 25% recovery in its NAV YTD (in USD), which l...
• 13% sales growth y-o-y, of which half was organic • EBITA margin of 9.
• Sales -8% vs. ABGSCe • Adj. EBITDA -44% vs. ABGSCe • Discontinuations have begun Q2'23 report The ...
Redeye provides its initial take on Mentice’s Q2 2023 report, which came in broadly above our estima...
Safeture reported a good Q2 2023, with the ARR growing in line with its financial target of 30% a ye...
Redeye comments on the Q2 report released earlier this morning.
Innofactor’s Q2 saw continued good growth, better than anticipated, up 18.
• EBIT SEK 143m (0% vs. ABGSCe 143m) • No material cons EBIT revisions expected • 11x '23e EV/EBIT (...
• Market saw a further sequential slowdown in Q2 • We cut '23e-'25e sales 9-3% on the weaker outlook...
Fiskars Q2 adjusted EBIT of EUR 23.4m came 14% below Refinitiv consensus expectation.
Redeye comments on SDS’s Q2 results, which showed higher sales and profitability than expected.
